ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 백혈구 성분채집술 기기 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년까지 CAGR 7.5%로 확대되어 9억 4,000만 달러로 성장할 것으로 예상됩니다. 예측기간에 예측되는 성장은 혈액 관련 질환의 유병률 상승, 암 이환율 증가, 말초혈 줄기세포 채취 수요 증가, 세포요법에서 백혈구성분채집술 사용 확대, 재생의료와 면역요법에 대한 투자 증가에 기인하고 있습니다. 이 기간에 예상되는 주요 동향으로는 성분채집술 기기의 기술 혁신, 자동화와 디지털 기술의 통합, 포인트 오브 케어 백혈구성분채집술 시스템의 진보, 클로즈드 루프 백혈구성분채집술 기술의 진보, 기술에 의한 세포 분리 효율의 향상 등이 있습니다.
혈액 관련 질환의 유병률 증가는 백혈구 성분채집술 기기 시장의 성장을 가속할 것으로 예측됩니다. 이러한 질병은 혈액 세포의 구조와 기능에 영향을 미치며 산소 수송, 면역 기능 및 혈액 응고의 합병증을 유발합니다. 이러한 증가의 주된 이유 중 하나는 빈혈, 백혈병 및 기타 혈액학적 질환과 같은 상태를 개발하기 쉬운 고령화 인구입니다. 백혈구 성분채집술 기기는 과도하거나 비정상적인 백혈구를 혈류에서 선택적으로 제거하여 백혈병 및 자가면역 질환과 같은 질병의 증상을 완화하고 합병증의 위험을 줄임으로써 이러한 질병을 관리하는 데 중요한 역할을 합니다. 예를 들어, 2024년 5월 호주 비영리 단체인 백혈병 재단은 2022년 약 1만 9403명의 호주인이 백혈병, 림프종, 골수종 등의 혈액암으로 진단되었다고 보고했습니다. 이것은 매일 약 53명, 즉 27분에 한 명이 새롭게 진단되는 것에 해당합니다. 현재 약 135,000명의 호주인이 혈액암과 혈액질환과 싸우고 있으며, 2035년에는 275,000명을 넘을 것으로 예측되고 있습니다. 혈액 관련 질환의 이러한 증가 추세는 백혈구 성분채집술 기기 수요 증가에 크게 기여합니다.
백혈구 성분채집술 기기 시장의 주요 기업은 치료 장비에 대한 액세스를 개선하고 국가 건강 관리 전략을 충족시키기 위해 지역 생산 능력에 대한 투자를 늘리고 있습니다. 현지 제조 시설의 설립은 공급망의 합리화, 수입품에 대한 의존도의 저감, 고도의 혈액 및 세포 채취 시스템의 저렴한 가격과 이용 가능성의 향상에 도움이 됩니다. 예를 들어, 2024년 11월 미국의 의료기술기업인 Terumo Blood and Cell Technologies는 중국의 자회사인 Terumo Medical Products(Hangzhou)와 협력하여 항저우에서 현지 생산을 시작했습니다. 이 이니셔티브는 중국에서 중국에서 널리 사용되는 치료적 연합, 줄기세포 수집 및 혈액 성분 분리를 포함하는 치료에 사용되는 Trima Accel Automated Blood Collection System 및 Spectra Optia Apheresis System과 같은 중요한 백혈구성분채집술 제품의 생산에 중점을 둡니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 백혈구 성분채집술 기기 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 백혈구 성분채집술 기기 시장 : 성장률 분석
세계의 백혈구 성분채집술 기기 시장 실적 : 규모와 성장, 2019-2024
세계의 백혈구 성분채집술 기기 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 백혈구 성분채집술 기기 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 백혈구 성분채집술 기기 시장 : 기기 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
치료적 백혈구성분채집술
혈구 제거 요법
줄기세포 채취
조사 용도
백혈구 분리 컬럼 및 세포 분리기
백혈구성분채집술용 일회용 제품
성분채집술 기기
세계의 백혈구 성분채집술 기기 시장 : 컴포넌트별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
백혈구 성분채집술 기기
채혈 세트
의료 소모품
필터
세계의 백혈구 성분채집술 기기 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
학술연구기관
제약 및 생명 공학 기업
혈액 성분 공급자
혈액 센터
세계의 백혈구 성분채집술 기기 시장 : 치료적 백혈구성분채집술 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
백혈병 치료 시스템
패혈증 치료 백혈구성분채집술 유닛
자가면역질환 관리 기기
세계의 백혈구 성분채집술 기기 시장 : 혈구 제거 요법 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
혈소판 성분 채취 기기
림프페레시스 유닛
적혈구 성분 분석 시스템
세계의 백혈구 성분채집술 기기 시장 : 줄기세포 채취 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
말초혈 줄기세포(Pbsc) 채취 기기
제대혈 채취 시스템
골수 줄기세포 성분채집술 시스템
세계의 백혈구 성분채집술 기기 시장 : 조사 용도 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
연구개발용 세포 분리 시스템
임상시험 성분채집술 플랫폼
학술연구실용 백혈구 성분채집술 기기
세계의 백혈구 성분채집술 기기 시장 : 백혈구 분리 컬럼 및 세포 분리기 유형별, 분석과 예측
흡착 컬럼
막 기반 세포 분리 시스템
원심식 세포 분리 기기
세계의 백혈구 성분채집술 기기 시장 : 백혈구성분채집술용 일회용 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
튜브 세트
바늘 및 카테터
컬렉션 가방
세계의 백혈구 성분채집술 기기 시장 : 성분채집술 기기 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
상용 플로우 성분채집술 기기
휴대용 또는 모바일 어페레시스 유닛
간헐 플로우 성분채집술 시스템
제7장 지역별/국가별 분석
세계의 백혈구 성분채집술 기기 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 백혈구 성분채집술 기기 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
백혈구 성분채집술 기기 시장 : 경쟁 구도
백혈구 성분채집술 기기 시장 : 기업 프로파일
Fresenius SE and Co. KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Asahi Kasei Medical Co. Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
Baxter International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Grifols SA : 개요, 제품 및 서비스, 전략 및 재무 분석
TERUMO BCT INC. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Kaneka Corporation
Charles River Laboratories International Inc.
Mallinckrodt Pharmaceuticals
Nikkiso Co. Ltd.
Haemonetics Corporation
Miltenyi Biotec GmbH
Macopharma
Precision for Medicine Inc.
B. Braun Melsungen AG
BioIVT LLC
AllCells LLC
Kawasumi Laboratories Inc.
Beijing Zksk Technology Co. Ltd.
Puriblood Medical Co. Ltd
Medica SpA
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
백혈구 성분채집술 기기 시장(2029년) : 새로운 기회를 제공하는 국가
백혈구 성분채집술 기기 시장(2029년) : 새로운 기회를 제공하는 부문
백혈구 성분채집술 기기 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
A leukapheresis device is a specialized medical tool designed to selectively isolate and collect white blood cells (leukocytes) from the blood of a patient or donor through centrifugation or filtration methods. It serves an essential function in therapies such as leukemia treatment, stem cell transplantation, and autoimmune disorder management, and is also utilized in clinical research and diagnostic procedures.
The primary categories of leukapheresis devices include therapeutic leukapheresis, cytapheresis, stem cell collection, research applications, leukapheresis columns and cell separators, leukapheresis disposables, and apheresis devices. Therapeutic leukapheresis is a medical technique employed to extract surplus or abnormal white blood cells from the bloodstream, aiming to alleviate symptoms or avoid related complications. These systems comprise various elements, including leukapheresis machines, blood collection sets, medical consumables, and filtration components. The diverse group of end users includes hospitals, academic and research organizations, pharmaceutical and biotechnology firms, blood centers, and providers of blood components.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The leukapheresis device market research report is one of a series of new reports from The Business Research Company that provides leukapheresis device market statistics, including the leukapheresis device industry's global market size, regional shares, competitors with the leukapheresis device market share, detailed leukapheresis device market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis device market. This leukapheresis device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The leukapheresis device market size has grown strongly in recent years. It will grow from $0.65 billion in 2024 to $0.70 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be credited to the rising demand for personalized medicine, enhanced emphasis on research and development, an increasing number of clinical trials, a growing elderly population, and the expanding adoption of minimally invasive procedures.
The leukapheresis device market size is expected to see strong growth in the next few years. It will grow to $0.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth projected for the forecast period can be attributed to the rising prevalence of blood-related disorders, increasing incidence of cancer, growing demand for peripheral blood stem cell collection, expanding use of leukapheresis in cellular therapies, and heightened investments in regenerative medicine and immunotherapy. Major trends anticipated during this period include technological innovations in apheresis devices, integration of automation and digital technologies, progress in point-of-care leukapheresis systems, advancements in closed-loop leukapheresis technologies, and technology-enhanced improvements in cell separation efficiency.
The increasing prevalence of blood-related disorders is anticipated to drive the growth of the leukapheresis device market. These disorders affect the structure or function of blood cells, leading to complications with oxygen transport, immune function, and blood clotting. One of the primary reasons for this rise is the aging population, which is more prone to developing conditions such as anemia, leukemia, and other hematologic diseases. Leukapheresis devices play a crucial role in managing these conditions by selectively removing excess or abnormal white blood cells from the bloodstream, thereby easing symptoms and lowering the risk of complications in illnesses like leukemia and autoimmune disorders. For example, in May 2024, the Leukaemia Foundation, an Australian non-profit organization, reported that in 2022, approximately 19,403 Australians were diagnosed with blood cancers, including leukemia, lymphoma, and myeloma. This equates to around 53 new cases each day, or one diagnosis every 27 minutes. Presently, nearly 135,000 Australians are living with a blood cancer or disorder, and projections indicate this number could exceed 275,000 by 2035. This upward trend in blood-related conditions is contributing significantly to the growing demand for leukapheresis devices.
Key players in the leukapheresis device market are increasingly investing in regional production capabilities to improve access to therapeutic devices and align with national healthcare strategies. Establishing local manufacturing facilities helps to streamline supply chains, reduce reliance on imports, and enhance the affordability and availability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology firm, collaborated with its China-based subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to initiate localized production in Hangzhou. This initiative focuses on producing vital leukapheresis products, such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are widely used in China for procedures including therapeutic apheresis, stem cell collection, and blood component separation.
In July 2022, Discovery Life Sciences, a US-based provider of highly characterized human biospecimens, completed the acquisition of AllCells LLC for an undisclosed sum. The acquisition is intended to create a comprehensive, scalable solution offering clients consistent access to high-quality human cellular starting materials along with integrated analytical services to support the development of cell and gene therapies. AllCells LLC, also based in the US, is a biotechnology company that specializes in leukapheresis devices for the targeted collection of blood cells.
Major players in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, and Medica S.p.A.
North America was the largest region in the leukapheresis device market in 2024. The regions covered in leukapheresis device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the leukapheresis device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The leukapheresis device market consists of sales of leukapheresis software and monitoring systems, blood flow controllers and pumps, and centrifuge rotors and tubing sets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Leukapheresis Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on leukapheresis device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for leukapheresis device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leukapheresis device market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Device Type: Therapeutic Leukapheresis; Cytapheresis; Stem Cell Collection; Research Applications; Leukapheresis Columns and Cell Separators; Leukapheresis Disposables; Apheresis Devices
2) By Component: Leukapheresis Machine; Blood Collection Set ; Medical Consumables ; Filters
3) By End User: Hospitals; Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Blood Component Providers; Blood Centers
2) By Cytapheresis: Plateletpheresis Devices; Lymphapheresis Units; Erythrocytapheresis Systems
3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices; Umbilical Cord Blood Collection Systems; Bone Marrow Stem Cell Apheresis Systems
4) By Research Applications: Cell Separation Systems for Research and Development; Clinical Trial Apheresis Platforms; Academic Laboratory Leukapheresis Devices
5) By Leukapheresis Columns And Cell Separators: Adsorption Columns; Membrane-Based Cell Separation Systems; Centrifugal Cell Separators
6) By Leukapheresis Disposables: Tubing Sets; Needles And Catheters; Collection Bags
7) By Apheresis Devices: Continuous Flow Apheresis Machines; Portable Or Mobile Apheresis Units; Intermittent Flow Apheresis Systems
Companies Mentioned: Fresenius SE and Co. KGaA; Asahi Kasei Medical Co. Ltd; Baxter International Inc.; Grifols S.A.; TERUMO BCT INC.; Kaneka Corporation; Charles River Laboratories International Inc.; Mallinckrodt Pharmaceuticals; Nikkiso Co. Ltd.; Haemonetics Corporation; Miltenyi Biotec GmbH; Macopharma; Precision for Medicine Inc.; B. Braun Melsungen AG; BioIVT LLC; AllCells LLC; Kawasumi Laboratories Inc.; Beijing Zksk Technology Co. Ltd.; Puriblood Medical Co. Ltd; Medica S.p.A.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Leukapheresis Device Market Characteristics
3. Leukapheresis Device Market Trends And Strategies
4. Leukapheresis Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Leukapheresis Device Growth Analysis And Strategic Analysis Framework
5.1. Global Leukapheresis Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Leukapheresis Device Market Growth Rate Analysis
5.4. Global Leukapheresis Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Leukapheresis Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Leukapheresis Device Total Addressable Market (TAM)
6. Leukapheresis Device Market Segmentation
6.1. Global Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutic Leukapheresis
Cytapheresis
Stem Cell Collection
Research Applications
Leukapheresis Columns and Cell Separators
Leukapheresis Disposables
Apheresis Devices
6.2. Global Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukapheresis Machine
Blood Collection Set
Medical Consumables
Filters
6.3. Global Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Academic Research Institutes
Pharmaceutical And Biotechnology Companies
Blood Component Providers
Blood Centers
6.4. Global Leukapheresis Device Market, Sub-Segmentation Of Therapeutic Leukapheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukemia Treatment Systems
Sepsis Treatment Leukapheresis Units
Autoimmune Disease Management Devices
6.5. Global Leukapheresis Device Market, Sub-Segmentation Of Cytapheresis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plateletpheresis Devices
Lymphapheresis Units
Erythrocytapheresis Systems
6.6. Global Leukapheresis Device Market, Sub-Segmentation Of Stem Cell Collection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.7. Global Leukapheresis Device Market, Sub-Segmentation Of Research Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell Separation Systems For Research And Development
Clinical Trial Apheresis Platforms
Academic Laboratory Leukapheresis Devices
6.8. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Columns And Cell Separators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adsorption Columns
Membrane-Based Cell Separation Systems
Centrifugal Cell Separators
6.9. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Disposables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tubing Sets
Needles And Catheters
Collection Bags
6.10. Global Leukapheresis Device Market, Sub-Segmentation Of Apheresis Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Continuous Flow Apheresis Machines
Portable Or Mobile Apheresis Units
Intermittent Flow Apheresis Systems
7. Leukapheresis Device Market Regional And Country Analysis
7.1. Global Leukapheresis Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Leukapheresis Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
